Strumento inattivo

Altre lingue Clinical Laserthermia Systems AB Swiss Exchange

Azioni

CLSR.B

SE0002756130

Prezzo di chiusura Swiss Exchange Altri mercati azionari
- ^SEK	-

31/05	Clinical Laserthermia Systems raccoglierà 59 milioni di corone svedesi attraverso un'emissione di diritti	MT
29/05	Clinical Laserthermia Systems AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Clinical Laserthermia Systems publishes annual report for 2023	07/06
BioStock: CLS' partner initiates full market release in the US	05/06
First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024	05/06
CLS presents its new strategic direction in a Business Update Event on June 12	05/06
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S	04/06
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue	31/05
CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m	30/05
CLS publishes interim report January - March 2024	29/05
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024	29/05
Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024	27/05
BioStock: CLS revises strategy - increases focus on neurosurgery	24/05
CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings	21/05
BioStock: CLS launches in France	15/05
CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company	14/05
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company	14/05
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory	30/04
CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators	30/04
Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split	19/04
Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB	12/04
BioStock: CLS makes progress in prostate cancer in Europe and the US	12/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Clinical Laserthermia Systems AB Swiss Exchange

Azioni

CLSR.B

SE0002756130

Altre lingue

Filtri